Gomekli 2 MG capsule 84S
Ended Awarded
- Contract number
- SPE2DB25FXC30
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,603
Award facts
- Contract value 100% obligated
- $23,602.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Gomekli 2 mg capsules (84-count units) with a contract ceiling value of $23,602.68. This firm fixed-price delivery order, with an ultimate completion date of September 22, 2025, represents a non-competitive procurement and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The DLA Troop Support Medical supply chain regularly utilizes this vehicle to fulfill delivery orders for various medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains in support of the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FXC30?
SPE2DB25FXC30 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 29, 2025.
How much is contract SPE2DB25FXC30 worth?
The government has obligated $23,603 on SPE2DB25FXC30.
Is contract SPE2DB25FXC30 an order under another contract?
Yes. SPE2DB25FXC30 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FXC30 competed?
The extent of competition for SPE2DB25FXC30 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award